Allspring Global Investments Holdings LLC Sells 9,245 Shares of The Clorox Company (NYSE:CLX)

Allspring Global Investments Holdings LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 6.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 136,184 shares of the company's stock after selling 9,245 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.11% of Clorox worth $22,039,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. Catalyst Capital Advisors LLC acquired a new stake in shares of Clorox during the third quarter worth $54,000. Los Angeles Capital Management LLC raised its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock valued at $31,266,000 after purchasing an additional 10,149 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock valued at $4,865,000 after purchasing an additional 9,037 shares in the last quarter. Natixis Advisors LLC raised its position in Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock valued at $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock worth $117,932,000 after acquiring an additional 13,038 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of CLX stock traded up $2.61 during trading hours on Wednesday, reaching $150.93. The company's stock had a trading volume of 982,411 shares, compared to its average volume of 1,319,275. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a market capitalization of $18.68 billion, a price-to-earnings ratio of 41.24, a PEG ratio of 2.53 and a beta of 0.42. The firm's 50 day simple moving average is $158.38 and its 200-day simple moving average is $159.74.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business earned $2.16 earnings per share. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Analysts Set New Price Targets

CLX has been the topic of several analyst reports. Barclays increased their price target on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research report on Wednesday, February 5th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Wells Fargo & Company lifted their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.